iScience (Feb 2024)

The implication of integrative multiple RNA modification-based subtypes in gastric cancer immunotherapy and prognosis

  • Xiangnan Zhang,
  • Liuxing Wu,
  • Liqing Jia,
  • Xin Hu,
  • Yanxin Yao,
  • Huahuan Liu,
  • Junfu Ma,
  • Wei Wang,
  • Lian Li,
  • Kexin Chen,
  • Ben Liu

Journal volume & issue
Vol. 27, no. 2
p. 108897

Abstract

Read online

Summary: Previous studies have focused on the impact of individual RNA modifications on tumor development. This study comprehensively investigated the effects of multiple RNA modifications, including m6A, alternative polyadenylation, pseudouridine, adenosine-to-inosine editing, and uridylation, on gastric cancer (GC). By analyzing 1,946 GC samples from eleven independent cohorts, we identified distinct clusters of RNA modification genes with varying survival rates and immunological characteristics. We assessed the chromatin activity of these RNA modification clusters through regulon enrichment analysis. A prognostic model was developed using Stepwise Regression and Random Survival Forest algorithms and validated in ten independent datasets. Notably, the low-risk group showed a more favorable prognosis and positive response to immune checkpoint blockade therapy. Single-cell RNA sequencing confirmed the abundant expression of signature genes in B cells and plasma cells. Overall, our findings shed light on the potential significance of multiple RNA modifications in GC prognosis, stemness development, and chemotherapy resistance.

Keywords